Literature DB >> 1396001

Cigarette smoking and nicotine delay postprandial mouth-cecum transit time.

A M Scott1, J E Kellow, G M Eckersley, J M Nolan, M P Jones.   

Abstract

The acute effects of both cigarette smoking and nicotine on postprandial mouth-cecum transit were studied in 20 habitual smokers, 10 males and 10 females. Mouth-cecum transit time was measured by the breath hydrogen technique, following ingestion of a standard mixed liquid meal. Each subject was studied on four separate occasions, either (1) sham or actively smoking two standard cigarettes, commencing 20 min after the meal, or (2) chewing two placebo or nicotine tablets over a 60-min period, commencing immediately after the meal. The time of administration of these stimuli was designed to minimize the effects on mouth-cecum transit time of alterations in gastric emptying. Mouth-cecum transit time was prolonged in response to both smoking [median and interquartile range: 120 (95, 150) min vs 100 (75, 140) min, P = 0.01] and nicotine [120 (80, 170) min vs 100 (70, 140) min, P = 0.002]. No difference was observed between sexes with respect to nicotine; the effect of smoking on mouth-cecum transit time, however, was less pronounced in females compared to males [difference active-placebo: 10 (10, 20) min vs 35 (20, 60) min, P = 0.01]. We conclude that acute cigarette smoking delays mouth-cecum transit time, an effect most likely due to nicotine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396001     DOI: 10.1007/bf01296500

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Mechanisms of acid reflux associated with cigarette smoking.

Authors:  P J Kahrilas; R R Gupta
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

2.  Smoking delays gastric emptying of solids.

Authors:  G Miller; K R Palmer; B Smith; C Ferrington; M V Merrick
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

3.  Effect of smoking on gastric acid secretion.

Authors:  W P Fung; C Y Tye
Journal:  Aust N Z J Med       Date:  1973-06

4.  Effects of nicotine and tyramine on contractile activity of the colon.

Authors:  N W Weisbrodt; C C Hug; S K Schmiege; P Bass
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

5.  Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests.

Authors:  A Rosenthal; N W Solomons
Journal:  Clin Chem       Date:  1983-11       Impact factor: 8.327

6.  Psychological stress and the passage of a standard meal through the stomach and small intestine in man.

Authors:  P A Cann; N W Read; J Cammack; H Childs; S Holden; R Kashman; J Longmore; S Nix; N Simms; K Swallow; J Weller
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

7.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

8.  Changes in food intake and activity after quitting smoking.

Authors:  S M Hall; R McGee; C Tunstall; J Duffy; N Benowitz
Journal:  J Consult Clin Psychol       Date:  1989-02

9.  Inhibition of pancreatic secretion in man by cigarette smoking.

Authors:  T E Bynum; T E Solomon; L R Johnson; E D Jacobson
Journal:  Gut       Date:  1972-05       Impact factor: 23.059

10.  Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit.

Authors:  J E Kellow; T J Borody; S F Phillips; A C Haddad; M L Brown
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

View more
  12 in total

Review 1.  Nicotine treatment for ulcerative colitis.

Authors:  M Guslandi
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 2.  Role of smoking in inflammatory bowel disease: implications for therapy.

Authors:  G A Thomas; J Rhodes; J T Green; C Richardson
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

3.  An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.

Authors:  J T Green; B K Evans; J Rhodes; G A Thomas; C Ranshaw; C Feyerabend; M A Russell
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

4.  Clinical guideline: management of gastroparesis.

Authors:  Michael Camilleri; Henry P Parkman; Mehnaz A Shafi; Thomas L Abell; Lauren Gerson
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

5.  Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.

Authors:  Kerryn W Reding; Kevin C Cain; Monica E Jarrett; Margaret D Eugenio; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

Review 6.  [Preoperative abstinence from smoking. An outdated dogma in anaesthesia?].

Authors:  B Zwissler; A Reither
Journal:  Anaesthesist       Date:  2005-06       Impact factor: 1.041

7.  The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.

Authors:  Yan-Ling He; Brian M Sadler; Ron Sabo; Sebastien Balez; Yibin Wang; Joelle Campestrini; Aziz Laurent; Monica Ligueros-Saylan; Dan Howard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

9.  Conservative treatment for anal incontinence.

Authors:  Dan Carter
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-03-18

Review 10.  Nicotine from cigarette smoking and diet and Parkinson disease: a review.

Authors:  Chaoran Ma; Yesong Liu; Samantha Neumann; Xiang Gao
Journal:  Transl Neurodegener       Date:  2017-07-02       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.